[1]
Mohammadi-Kebar, Y., Zandian, H. and Khazdooz, Z. 2023. The impact of anti-tumor necrosis factor alpha drugs on lipid profile of patients with rheumatoid arthritis or seronegative spondyloarthropathy. International Journal of Basic & Clinical Pharmacology. 13, 1 (Dec. 2023), 47–50. DOI:https://doi.org/10.18203/2319-2003.ijbcp20233890.